Hemodynamic and autonomic effects of smokeless tobacco in healthy young men

被引:36
作者
Wolk, R
Shamsuzzaman, ASM
Svatikova, A
Huyber, CM
Huck, C
Narkiewicz, K
Somers, VK
机构
[1] Mayo Clin, Rochester, MI USA
[2] Med Univ Gdansk, Gdansk, Poland
关键词
D O I
10.1016/j.jacc.2004.11.056
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The aim of this study was to investigate the acute hemodynamic and autonomic effects of smokeless tobacco. BACKGROUND Smokeless tobacco use is increasing. Its cardiovascular effects are not well understood. METHODS Sixteen healthy, male, habitual snuff tobacco users (aged 22 +/- 1 year) were studied, using a randomized, double-blind, placebo-controlled, crossover design with two separate experimental sessions: placebo and tobacco. Muscle sympathetic nerve activity (MSNA), electrocardiogram, blood pressure, calf blood flow, nicotine, and catecholamines were measured. RESULTS Snuff tobacco increased plasma nicotine from 2.8 +/- 0.5 ng/ml to 10.4 +/- 1.1 ng/ml. Mean blood pressure increased by 10 +/- 1 mm Hg, and heart rate increased by 16 +/- 2 beats/min. Peripheral vascular resistance, MSNA, and norepinephrine concentration did not change with tobacco, but epinephrine increased by similar to 50%. CONCLUSIONS Oral snuff tobacco increases heart rate, blood pressure, and epinephrine. Despite the increase in blood pressure, there is no decrease in either MSNA or peripheral vascular resistance. Smokeless tobacco is a powerful autonomic and hemodynamic stimulus. Catecholamine release from the adrenal medulla likely contributes to this response. (c) 2005 by the American College of Cardiology Foundation.
引用
收藏
页码:910 / 914
页数:5
相关论文
共 23 条
[1]   Chronic disease mortality in a cohort of smokeless tobacco users [J].
Accortt, NA ;
Waterbor, JW ;
Beall, C ;
Howard, G .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (08) :730-737
[2]   Smokeless tobacco as a possible risk factor for stroke in men - A nested case-control study [J].
Asplund, K ;
Nasic, S ;
Janlert, U ;
Stegmayr, B .
STROKE, 2003, 34 (07) :1754-1759
[3]   Smokeless tobacco and cardiovascular disease [J].
Asplund, K .
PROGRESS IN CARDIOVASCULAR DISEASES, 2003, 45 (05) :383-394
[4]  
Badimon L, 1999, THROMB HAEMOSTASIS, V82, P1736
[5]   NICOTINE ABSORPTION AND CARDIOVASCULAR EFFECTS WITH SMOKELESS TOBACCO USE - COMPARISON WITH CIGARETTES AND NICOTINE GUM [J].
BENOWITZ, NL ;
PORCHET, H ;
SHEINER, L ;
JACOB, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (01) :23-28
[6]   DAILY USE OF SMOKELESS TOBACCO - SYSTEMIC EFFECTS [J].
BENOWITZ, NL ;
JACOB, P ;
YU, L .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (02) :112-116
[7]   SMOKELESS TOBACCO USE AND INCREASED CARDIOVASCULAR MORTALITY AMONG SWEDISH CONSTRUCTION WORKERS [J].
BOLINDER, G ;
ALFREDSSON, L ;
ENGLUND, A ;
DEFAIRE, U .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1994, 84 (03) :399-404
[8]   USE OF SMOKELESS TOBACCO IN MAJOR-LEAGUE BASEBALL [J].
CONNOLLY, GN ;
ORLEANS, CT ;
KOGAN, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (19) :1281-1285
[9]  
ERNSTER VL, 1990, JAMA-J AM MED ASSOC, V264, P218
[10]   Pharmacokinetics and pharmacodynamics of moist snuff in humans [J].
Fant, RV ;
Henningfield, JE ;
Nelson, RA ;
Pickworth, WB .
TOBACCO CONTROL, 1999, 8 (04) :387-392